Regeneron Pharma REG has outperformed the market by 11.39% on an annualized basis over the last 5 years and has produced a compound annual return of 20.58%. Regeneron Pharmaceuticals currently has a market cap of $88.08 billion.

Purchase of $100 in REGN: If an investor bought $100 worth of REGN stock 5 years ago, it would be worth it $256.37 today based on a price of $805.64 for REGN at the time of writing.

Regeneron Pharmaceuticals’ performance over the past 5 years

Finally – what is all this? The most important takeaway to take from this article is how much of a difference compound returns can make in your cash growth over a period of time.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.